Deputy Director, Milner Therapeutics Institute
Kathryn Chapman's interests are in facilitating academic/industry interactions to accelerate drug development. Learn more.
Research AreasTherapeutics
Target validation
Functional genomics
Disease signature identification and interrogation
|
TechniquesComplex cellular models and assays
Genetic screening
Live cell imaging
CRISPR
|
Areas for CollaborationDrug development
Academic/industry interactions Artificial Intelligence and machine learning Target validation Complex cellular assay development and screening
|
Research Theme
